Skip to main content

Liver Stiffness clinical trials at University of California Health

1 research study open to eligible people

Showing trials for
  • Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness

    open to eligible people ages 18 years and up

    The primary objective of this study is to evaluate the effect of setanaxib on biochemical response at Week 52 in participants with primary biliary cholangitis (PBC) and with elevated liver stiffness and intolerance or inadequate response to ursodeoxycholic acid (UDCA).

    at UC Davis

Last updated: